IRF4 and experimental autoimmune encephalomyelitis: For example, CD11c+ DCs from the IRF4 siRNA-treated mice showed significantly decreased inflammatory cytokines including IL-23, resulting in ameliorating experimental autoimmune encephalomyelitis in IRF4 siRNA-treated mice [20].